We monitored tumor growth following injection of 1 × 106 FAK-deficient cells (FAK−/−) or FAK-deficient cells that re-expressed wild-type FAK (FAK-WT) at comparable levels to endogenous FAK in both CD-1 nude and FVB (syngeneic) host mouse strains. This evidence concerns the gene PTK2 and neoplasm.